Page last updated: 2024-09-02

ci 988 and Lung Neoplasms

ci 988 has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, RT; Moody, TW; Moreno, P; Nuche-Berenguer, B1
Jensen, RT; Moody, TW1

Other Studies

2 other study(ies) available for ci 988 and Lung Neoplasms

ArticleYear
CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
    Journal of molecular neuroscience : MN, 2015, Volume: 56, Issue:3

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dipeptides; ErbB Receptors; Gastrins; Gefitinib; Hormone Antagonists; Humans; Indoles; Lung Neoplasms; Meglumine; Pyrimidines; Quinazolines

2015
CI-988 inhibits growth of small cell lung cancer cells.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 299, Issue:3

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Drug Screening Assays, Antitumor; Humans; Indoles; Lung Neoplasms; Meglumine; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tumor Cells, Cultured

2001